HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
LQDA
Liquidia Corp
Healthcare Biotechnology · North Carolina, USA · Reports in usd
Market Cap: $4.99B
Market Cap
$4.99B
Enterprise Val
$4.95B
P/E Ratio
223.59
P/B Ratio
45.93
Trailing PEG (1Y)
-0.96
As Of
May 11, 2026

Overview & Key Metrics

Reporting period: Mar 31, 2026 · Q1 2026
Book Value$108.6M
Gross Margin91.08%
Profit Margin91.08%
Return on Equity46.82%
Return on Assets7.06%
Current Ratio2.22
Debt/Equity1.70
LT Debt/Equity1.23
Revenue Per Share1.51

Income Statement

Mar 31, 2026
Revenue$132.9M
Cost of Revenue$11.9M
Gross Profit$121.0M
R&D$12.6M
SG&A$46.9M
Operating Expenses$59.5M
Operating Income$61.5M
Interest Expense$6.5M
Tax Expense$3.9M
Net Income$52.9M
EPS (Basic)$0.60
EPS (Diluted)$0.52
EBIT$63.3M
EBITDA$63.4M
Consolidated Income$52.9M
Non-Controlling Interests$0.00

Balance Sheet

Mar 31, 2026
Cash & Equivalents$226.3M
Accounts Receivable$74.2M
Inventory$28.5M
Current Assets$333.1M
LT Investments$0.00
Property, Plant & Equipment$25.2M
Intangibles$6.8M
Non-Current Assets$68.5M
Total Assets$401.5M
Accounts Payable$11.0M
Current Debt$51.0M
Current Liabilities$149.7M
LT Debt$133.8M
Non-Current Liabilities$143.2M
Total Liabilities$293.0M
Total Debt$184.8M
Retained Earnings-$573.5M
Shareholder Equity$108.6M
Shares Outstanding88,114,429

Cash Flow Statement

Mar 31, 2026
Operating Cash Flow$53.0M
Investing Cash Flow-$2.8M
Financing Cash Flow-$18.1M
CapEx-$2.8M
Free Cash Flow$50.2M
Depreciation & Amort.$88.0K
Stock-Based Comp$9.2M
Acquisitions / Disposals$0.00
Investment Activity$0.00
Debt Issued/Repaid-$20.0M
Equity Issued/Repaid$1.8M
Dividends Paid$0.00
Net Change in Cash$32.1M
Data cached · Meta cache · Daily cache · Statements cache · TTL 24h